(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics
 
 
Alternative Scenarios - 3
Blood Banking - 105
Cancer - 92
Clinical Chemistry - 262
Coagulation - 89
Decentralized Testing - 3
DNA Probes/Biochips - 33
Genetic Testing - 1
Hematology/Flow Cytometry - 98
Hemostasis - 70
Histology/Cytology - 2
Immunodiagnostics - 26
Infectious Diseases - 295
Microbiology Testing - 80
Molecular Diagnostics - 141
NAT - 82
POC Testing - 163
Strategic Planning - 24
Top 10 Companies - 22
Transfusion Testing - 84
Tumor Markers - 75
 
 In Vitro Diagnostics Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  3  4  5  6  7  8  9  10  11  12  Next »
2023 Competing in the European Cancer Diagnostics Market:
France, Germany, Italy, Spain, UK


This new five-country report from Venture Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, Italy, Spain, and the UK; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.



 

$7500.00
       
Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This new report from Venture Planning Group provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers.

The report presents:

Estimated numbers of cancer testing laboratories, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, U....


 

$7500.00
       
2023 Coagulation Testing in Europe: Market Segment Forecasts and Supplier Shares

This unique report provides information not available from any other published source, including test and sales forecasts by market segment, as well as major reagent and instrument suppliers sales and market shares.

This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the coagulation market during the next five years....


 

$7500.00
       
2023 Middle East Coagulation Testing Market: Reagent and Instrument Sales Forecasts, Volume Projections for 40 Tests, Competitive Strategies, Instrumentation Review, Innovative Technologies, Opportunities for Suppliers

This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$7500.00
       
2023 North America Coagulation Testing Market: Reagent and Instrument Sales Forecasts, Volume Projections for 40 Tests, Competitive Strategies, Instrumentation Review, Innovative Technologies, Opportunities for Suppliers

This new 3-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$7500.00
       
2022 Infectious Diseases in Europe: Market Segment Forecasts and Supplier Shares

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test.

This comprehensive European survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies....


 

$7500.00
       
2023 Clinical Chemistry and Immunodiagnostics in Europe: Market Segment Forecasts and Supplier Shares

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test.

This market intelligence and technology assessment report will help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses....


 

$7500.00
       
2023 Middle East Clinical Chemistry Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor Marker Tests--Competitive Strategies, Instrumentation Review, Opportunities

This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$7500.00
       
2023 North America Clinical Chemistry Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor Marker Tests--Supplier Shares, Competitive Strategies, Opportunities

This new 3-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$7500.00
       
2023 Competing in the European Hematology and Flow Cytometry Markets: France, Germany, Italy, Spain, UK

This new five-country study from Venture Planning Group presents test volume forecasts, instrument placements and installed base by manufacturer and model, as well as sales and market shares of leading instrument and reagents suppliers. For each country the report provides:



 

$7500.00
       
2023 Analysis of the Latin American Molecular Diagnostics Market:Sales Forecasts and Competitive Strategies

This new comprehensive 22-country report from VPGMarketResearch is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the Latin America molecular diagnostics market during the next five years. The report explores business and technological trends; provides 5-year test volume/sales forecasts; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

 

$7500.00
       
2023 Asia-Pacific Molecular Diagnostics Market: Sales Forecasts, Supplier Shares and Strategies-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

This new 18-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$7500.00
       
2023 Middle East Immunodiagnostics Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor Marker Tests--Competitive Strategies, Instrumentation Review, Opportunities

This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test.


 

$7500.00
       
2023 North America Immunodiagnostics Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor Marker Tests--Supplier Shares, Competitive Strategies, Opportunities

This new 3-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$7500.00
       
2023 Tumor Markers in Europe: Market Segment Forecasts and Supplier Shares

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test.

This comprehensive five-country report identifies and evaluates major business opportunities emerging in the tumor markers market during the next five years; examines trends in France, Germany, Italy, Spain, and the UK; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers....


 

$7500.00
       
2023 Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU)

This report provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers....


 

$7500.00
       
2023 Transfusion Diagnostics in Europe: Market Segment Forecasts and Supplier Shares

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test.

This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European blood banking market during the next five years, and to assist industry executives in developing effective business, new product development and marketing strategies....


 

$7500.00
       
2023 Middle East Transfusion Diagnostics Market: Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$7500.00
       
« Previous     3  4  5  6  7  8  9  10  11  12   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X